Earlier, he worked with Cadila Pharmaceuticals Limited, Cipla, Alkem Laboratories, and Wockhardt, and started his career with Novartis
Uppilliappan joined Dr. Lal Pathlabs in 2016 as Chief Operating Officer and later became CEO
Sharma joined the Morepen Lab in 2004
The Board has elected Dr. Ajit Shetty, who had served as the Company's Interim Chairperson of the Board since December 9, 2023, as Chairperson of the Board, effective February 13, 2024
An accomplished R&D leader and champion of the application of AI to drug discovery
He is a former Neurology faculty member at The Johns Hopkins Hospital and an elected Fellow of the Royal College of Physicians, United Kingdom
He is also inducted as a member of the management council and senior management personnel of the company
His resignation would be effective from March 18, 2024
His most recent stint was with Danone India as its Managing Director
Announces changes to commercial organization to prepare for multiple product launches in 2024 and 2025
Prior to joining Alembic, he was working with Lupin Limited for more than 11 years
Currently, Venkat is Lead – Market Access, India at Pfizer
He has 37 years of experience in API Intermediaries, Pharma and Chemicals industr
Prateek has more than 23 years of rich experience in Human Resource
He will be responsible for leading all the activities related to the Research & Development (Formulations) Division of the company
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri
Subscribe To Our Newsletter & Stay Updated
